Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

KRN 5500

Next Previous
X
Search
Drug Profile

KRN 5500

Alternative Names: KRN5500; NSC-650426; SPK-241

Latest Information Update: 01 Feb 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Kirin Brewery; Massachusetts General Hospital
  • Developer Fortovia Therapeutics
  • Class Cytostatic antibiotics; Non-opioid analgesics; Purine nucleosides
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Multiple myeloma; Neuropathic pain
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Neuropathic pain
  • Discontinued Cancer; Multiple myeloma

Most Recent Events

  • 01 Feb 2023 Discontinued - Preclinical for Multiple myeloma in USA (IV)
  • 13 Nov 2018 Midatech Pharma US has been acquired by Kanwa Holdings
  • 28 Jul 2018 No recent reports of development identified for preclinical development in Multiple-myeloma in USA (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top